Detecting and Treating HER2 Alterations in Metastatic Colorectal Cancer: Expert and Patient Perspectives : Episode 8
Appropriate Patient Selection for Patients with HER2+ Metastatic Colorectal Cancer for Anti-HER2 Therapies
Dr Tanios Bekaii-Saab describes for which patient groups he would use anti-HER2 therapies as a second-line treatment for HER2+ metastatic colorectal cancer.
OND0539_CRC_ATP_Seg08_REGIMENS
Video Player is loading.
Recent Videos
CAR T in High-Risk DLBCL: Making the Right Choice in Aggressive Disease
PSMA PET Imaging Agents: Image Quality and Diagnostic Performance
Transplant-Eligible, CAR T Considered: How Do We Decide?
The Evolving Role of PSMA PET in Prostate Cancer Imaging and Management
Auto-SCT or CAR T? A Case-Based Discussion in Relapsed DLBCL
Personalizing CAR T: Making the Right Call for Each Patient
Rethinking CAR T Timing: Insights on CAR T Efficacy and Patient Selection
CAR T in the Real World: Clinician Perspectives on Outcomes, Toxicity, and Patient Management
TRANSFORM and ZUMA-7: A Discussion on Efficacy and Safety of CAR T in R/R DLBCL
Tailoring Therapy: Patient-Specific Decision-Making in Relapsed DLBCL
Related Content
